As of 2025-04-24, the Fair Value of Summit Therapeutics Inc (SMMT) is -1.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.35 USD, the upside of Summit Therapeutics Inc is -104.41%.
With the market price of 27.35 USD and our fair value calculation, Summit Therapeutics Inc (SMMT) is not a good investment. Investing in SMMT stocks now will result in a potential loss of 104.41%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -52.70 | -88.60 | -78.78 | -614.93 | -221.31 | -211.26 |
| YoY growth | -80.91% | -68.12% | 11.08% | -680.56% | 64.01% | -150.90% |
| Market Cap (mil) | 20,169.26 |
| P/E | |
| Forward P/E |
| EPS | -0.24 |
| Avg earnings growth rate | -150.90% |
| TTM earnings | -177.84 |